Xia, Lu
Lin, Hexin
Cao, Huifen
Lian, Jiabian
Funding for this research was provided by:
National Natural Science Foundation of China (81802268)
Xiamen Cell Therapy Research Center (3502220214001)
Xiamen Cell Therapy Research Center (3502220214001)
Xiamen Cell Therapy Research Center (3502220214001)
Article History
Received: 18 January 2024
Accepted: 18 April 2024
First Online: 6 May 2024
Declarations
:
: This study was approved by the Ethical Review Board of Shanghai OUTDO Biotech Co., Ltd. (Approval Number: SHYJS-CP-2206001). Informed consent was obtained from all subjects and/or their legal guardian(s). All animal experiments were in compliance with ethical regulations and approved by the Animal Ethics Committee of Xiamen University (Approval Number: XMULAC20180066).
: Not applicable.
: The authors declare no competing interests.